Immunologists and oncologists are using adoptive cell transfer techniques to manipulate the body's immune system against cancer and other diseases. In the normal immune response, one type of leukocyte called T-cell expands its number after being directed by another immune cell called antigen-presenting cell (APC) and remains viable.